Remove 2015 Remove Confidentiality Remove Licensing Remove Settlement
article thumbnail

NPE Showcase – Sockeye Licensing

LexBlog IP

This installment will focus on a company named Sockeye Licensing TX, LLC. Sockeye has sued approximately 80 defendants since it began its patent infringement campaigns in 2015. For example, Sockeye sued a group of electronics companies in 2015 and sued the same defendants again in 2022 with at least some of the same patents.

article thumbnail

HIT NETFLIX CONTENT AND THE COPYRIGHT INFRINGEMENT THAT FOLLOWS

JIPL Online

Then, the post will predict how Netflix may shift its content practices, defense strategies, and settlement tactics as a result of their past litigation successes in copyright actions. SETTLEMENT CASES. 9] Both parties reached an amicable settlement. [10] 9] Both parties reached an amicable settlement. [10] TRIAL CASES.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Are Courts Finally Getting Fed Up With Copyright Shakedowns?

Copyright Lately

Liebowitz is probably the best known example of a copyright troll, a moniker that one circuit court defined as a someone who brings “strategic infringement claims of dubious merit in the hope of arranging prompt settlements with defendants who would prefer to pay modest or nuisance settlements rather than be tied up in expensive litigation.”.

article thumbnail

SpicyIP Weekly Review (March 4-March 10)

SpicyIP

In addition to the permanent injunction, the Court imposed damages worth INR 15 Lakhs in favor of the plaintiff, relying on an earlier settlement between the parties, a plethora of precedents, and Rule 20 of the IPD Rules. The defendants had five licenses for the plaintiff’s Nuke software, which expired on September 20, 2020.

article thumbnail

Biosimilars 2020 Year in Review

Fish & Richardson Trademark & Copyright Thoughts

For the first time since FDA licensed the first biosimilar, Sandoz’s Zarxio ® (filgrastim-sndz), in 2015, the United States saw a decrease in annual biosimilar approvals in 2020. Figure 1, below, provides a snapshot of FDA approval and biosimilar product launch trends from 2015 through 2020. 2015; resubmitted Feb.

article thumbnail

India’s High Court of Delhi issues guidance on SEP licensing that seeks to harmonize decisions in other countries (Intex v. Ericsson)

LexBlog IP

This is an important decision to review in understanding licensing and litigation of international SEP portfolios. This decision indicates that a FRAND commitment is not a one-way street, but imposes obligations on both the SEP owner and someone seeking to license the SEP. This decision indicates they should.

article thumbnail

Guest Post: Third-Party Litigation Funding: Disclosure to Courts, Congress, and the Executive

Patently-O

It generally amounts to more than 50% of the total settlement recovery, acknowledging, at least by basic math, that they are the primary beneficiary of the litigation.). self-reporting that “IP EDGE has returned over 3x the money it has invested in patents in the 2015-2021 time period with no down years”). [16]